文献速递新生儿儿童心血管与肾脏儿童呼吸

早产儿动脉导管未闭的解读

Patent Ductus Arteriosus of the Preterm Infant.
PubMed 文献 · Pediatrics · 2020-01-01

本文综述了早产儿动脉导管未闭(PDA)的病理生理机制、临床后果及治疗策略。产后导管闭合受氧张力升高、血管扩张介质撤退及多种血管收缩因素调控;持续性PDA可导致左向右分流,增加支气管肺发育不良、坏死性小肠结肠炎、脑室内出血及死亡风险。近十年治疗趋于保守,但特定亚组(如<26+0/7周、<750g)可能从预防性吲哚美辛、早期靶向治疗或救援性闭合中获益,文中还提出了分期治疗算法。

要点

  • 早产儿持续性PDA可致左向右分流,增加BPD、NEC、IVH及死亡风险。
  • 近十年PDA治疗趋势更保守,但高危亚组可能从干预中获益。
  • 对<26+0/7周、<750g新生儿可考虑预防性静脉吲哚美辛。

核心结论

  • 持续性PDA在早产儿中可产生临床后果,包括增加 prolonged ventilation、BPD、NEC或局灶性肠穿孔、IVH及死亡风险。
  • 近十年对早产儿PDA的治疗趋于不积极,但特定高危亚组可能从药物、介入或手术干预中获益。

研究设计与样本

  • 本文为综述,未报告系统检索范围或样本量。

主要发现

  • 产后导管闭合由氧张力升高、血管扩张介质(前列腺素、一氧化氮、腺苷)撤退及血管收缩因素(内皮素-1、儿茶酚胺、收缩性前列腺素类)、离子通道、钙流、血小板、形态成熟及有利遗传倾向共同刺激。
  • 极低胎龄新生儿中肺血管阻力下降增加经导管左向右分流及肺血流,导致间质性肺水肿和左心容量负荷。
  • 血流动力学显著PDA(hsPDA)的左向右分流潜在后果包括延长通气、BPD、NEC或局灶性肠穿孔、IVH及死亡风险增加。

关键数值与推荐

  • 对高度选择的极低胎龄新生儿(<26+0/7周妊娠、<750g出生体重)伴PDA可预防性静脉使用吲哚美辛。
  • 对PDA相关并发症特别高风险的特定早产儿可考虑早期靶向治疗。
  • 对hsPDA闭合,可考虑PDA结扎、导管介入或口服对乙酰氨基酚作为救援选项。
  • hsPDA导管闭合对临床结局的影响需未来前瞻性研究确定。
  • 文中提供了整合多种治疗模式的分期治疗算法。

临床怎么用

  • 临床应识别hsPDA高危早产儿,权衡保守观察与干预的获益风险。
  • 对<26+0/7周、<750g的极低胎龄新生儿,可考虑预防性静脉吲哚美辛。
  • 对hsPDA,可将结扎、导管介入或口服对乙酰氨基酚作为救援选项。

局限性

  • 本文为综述,未报告系统检索策略、纳入研究数量或证据等级。
  • hsPDA导管闭合对临床结局的影响尚需未来前瞻性研究确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Postnatal ductal closure is stimulated by rising oxygen tension and withdrawal of vasodilatory mediators (prostaglandins, nitric oxide, adenosine) and by vasoconstrictors (endothelin-1, catecholamines, contractile prostanoids), ion channels, calcium flux, platelets, morphologic maturity, and a favorable genetic predisposition. A persistently patent ductus arteriosus (PDA) in preterm infants can have clinical consequences. Decreasing pulmonary vascular resistance, especially in extremely low gestational age newborns, increases left-to-right shunting through the ductus and increases pulmonary blood flow further, leading to interstitial pulmonary edema and volume load to the left heart. Potential consequences of left-to-right shunting via a hemodynamically significant patent ductus arteriosus (hsPDA) include increased risk for prolonged ventilation, bronchopulmonary dysplasia, necrotizing enterocolitis or focal intestinal perforation, intraventricular hemorrhage, and death. In the last decade, there has been a trend toward less aggressive treatment of PDA in preterm infants. However, there is a subgroup of infants who will likely benefit from intervention, be it pharmacologic, interventional, or surgical: (1) prophylactic intravenous indomethacin in highly selected extremely low gestational age newborns with PDA (<26 + 0/7 weeks' gestation, <750 g birth weight), (2) early targeted therapy of PDA in selected preterm infants at particular high risk for PDA-associated complications, and (3) PDA ligation, catheter intervention, or oral paracetamol may be considered as rescue options for hsPDA closure. The impact of catheter-based closure of hsPDA on clinical outcomes should be determined in future prospective studies. Finally, we provide a novel treatment algorithm for PDA in preterm infants that integrates the several treatment modalities in a staged approach.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Hamrick SEG, Sallmon H, Rose AT, et al. Patent Ductus Arteriosus of the Preterm Infant. Pediatrics. 2020. PMID: 33093140. doi:10.1542/peds.2020-1209

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。